CHRU Clermont- Ferrand CHU Estaing

Clermont-Ferrand, Auvergne 63000

0 studies enrolling now · 1 studies all time

What they study most

Diffuse Large B-cell Lymphoma

Studies at this site

• TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early